Cite
MLA Citation
D. Parmar et al.. “Saroglitazar magnesium improves lipid parameters in patients with non-alcoholic fatty liver disease / non-alcoholic steatohepatitis.” Atherosclerosis, vol. 315, 2020, pp. e47–. http://access.bl.uk/ark:/81055/vdc_100117936262.0x00005f